The telehealth market for weight loss medication has matured rapidly. Dozens of platforms now prescribe GLP-1 medications, each with different pricing, medication access, and clinical support models. This guide compares the major categories and helps you identify what actually matters when choosing.
What to compare beyond price
Price is the number most people look at first, but three other factors determine whether a platform is worth your money. First, medication access: does the platform offer FDA-approved brand-name drugs, compounded alternatives, or both? Second, clinical support: do you get a dedicated provider who knows your history, or a rotating roster of clinicians who see your chart for the first time each visit? Third, insurance integration: some platforms help you check and use your insurance benefits, while others are cash-pay only.
Platform categories in 2026
Brand-name focused platforms
Companies like Ro, Hims & Hers, and Sesame have shifted toward FDA-approved medications — Wegovy, Wegovy pill, Zepbound, and Foundayo. These platforms often integrate with manufacturer savings programs and insurance checking tools. Monthly costs range from $149 to $349 for medication, plus membership or consultation fees. The trade-off is higher cost for FDA-regulated quality and supply chain reliability.
Multi-treatment telehealth platforms
Platforms that offer GLP-1s alongside other treatments — ED medication, hair loss, hormone therapy — provide convenience for patients managing multiple conditions. The clinical depth varies widely. Some use the same provider across your treatments; others silo each condition into a separate workflow with different clinicians.
Compounded GLP-1 providers
Following the FDA's resolution of semaglutide and tirzepatide shortage designations, the regulatory landscape for compounded GLP-1s has tightened. Providers offering compounded medications at lower prices ($150–$300/month) must now work within narrower legal frameworks — different formulations, alternative doses, or combination products rather than direct copies of brand-name drugs. Verify the compounding pharmacy's accreditation status before committing.
Red flags across all categories
Regardless of which type of platform you consider, watch for these warning signs: no health questionnaire before prescribing, guaranteed approval before medical evaluation, no licensed prescriber in the care pathway, prices that seem dramatically below market rates, and any platform that appeared on the FDA's March 2026 warning letter list.
Our Assessment
There's no single "best" platform — the right choice depends on your insurance situation, medication preference (pill vs. injection, brand vs. compounded), and how much clinical support you need. Start by checking your insurance coverage, then compare platforms within the category that fits your access pathway.
The platforms investing most heavily in clinical quality — dedicated providers, proactive follow-up, lab integration — are generally worth the modest premium over bare-bones prescription mills.